20/20 GeneSystems
Pioneering the Multi-Cancer Early Detection (MCED) blood testing market
Overview
Raised: $113,019
Total Commitments ($USD)
Wefunder
05/05/2024
09/04/2024
$500
Equity - Preferred
Series A
RegCF
$5.34
$69,859,000
Rolling Commitments ($USD)
Active
05/18/2024
108
226%
2%
$8,694
66
2000
Healthcare & Pharmaceuticals
HealthTech
B2B/B2C
Medium
Low
Summary Profit and Loss Statement
| FY 2023 | FY 2022 | |
|---|---|---|
|
Revenue |
$1,424,304 |
$11,059,145 |
|
COGS |
$1,315,166 |
$5,937,398 |
|
Tax |
$0 |
$0 |
| ||
| ||
|
Net Income |
$-6,391,309 |
$2,186,875 |
Summary Balance Sheet
| FY 2023 | FY 2022 | |
|---|---|---|
|
Cash |
$4,089,461 |
$8,807,575 |
|
Accounts Receivable |
$68,834 |
$764,924 |
|
Total Assets |
$6,367,828 |
$12,215,021 |
|
Short-Term Debt |
$1,011,623 |
$1,630,171 |
|
Long-Term Debt |
$1,068,713 |
$1,210,584 |
|
Total Liabilities |
$2,080,336 |
$2,840,755 |
Raise History
| Offering Name | Close Date | Platform | Valuation/Cap | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|---|
| 20/20 GeneSystems | 09/03/2024 | Wefunder | $69,859,000 | $113,019 | Equity - Preferred | Active | RegCF |
| 20/20 GeneSystems | 12/20/2022 | StartEngine | $58,400,000 | $232,704 | Convertible Note | Funded | RegCF |
| 20/20 GeneSystems | 06/26/2021 | StartEngine | $38,500,000 | $2,903,017 | Equity - Preferred | Funded | RegA+ |
| 20/20 GeneSystems | 10/31/2020 | SeedInvest | $38,500,000 | $3,792,229 | Equity - Preferred | Funded | RegA+ |
| 20/20 GeneSystems | 12/13/2017 | Microventures | $23,000,000 | $1,064,807 | Equity - Preferred | Funded | RegCF |
Price per Share History
Note: Share prices shown in earlier rounds may not be indicative of any stock splits.
Valuation History
Revenue History
Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.
Employee History
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
